EyePoint Pharmaceuticals
2,256
$0.739876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.006 (+0.83%) Today
+$0.0025 (+0.34%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell EYPT and other stocks, options, ETFs, and crypto commission-free!
About EYPT
EyePoint Pharmaceuticals, Inc. Common Stock, also called EyePoint Pharmaceuticals, is a biopharmaceutical company. Read More It engages in the development and commercializing of ophthalmic products. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
Employees
84
Headquarters
Watertown, Massachusetts
Founded
1987
Market Cap
90.75M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.71M
High Today
$0.745
Low Today
$0.71
Open Price
$0.73
Volume
447.46K
52 Week High
$2.69
52 Week Low
$0.70
Collections
EYPT Earnings
-$0.20
-$0.13
-$0.07
$0.00
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Estimated
— per share
Actual
Expected Aug 5, Pre-Market